Tokiko Watanabe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tokiko Watanabe has a total of 167 co-authors. Here are the top co-authors by number of shared publications:
- Yoshihiro Kawaoka
Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, USA
15 shared publications - Itsuki Anzai
Department of Molecular Virology Research Institute for Microbial Diseases Osaka University 3-1 Yamadaoka Suita Osaka 565-0871 Japan
7 shared publications Kosuke Takada
Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan
7 shared publicationsYurie Kida
Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan
7 shared publicationsChikako Ono
Center for Infectious Disease Education and Research (CiDER), The University of Osaka, Yamadaoka 1-10, Suita, Osaka, 565-0871, Japan; Center for Advanced Modalities and DDS (CAMaD), The University of Osaka, Yamadaoka 3-1, Suita, Osaka, 565-0871, Japan; Laboratory of Virus Control, Research Institute for Microbial Diseases, The University of Osaka, Yamadaoka 3-1, Suita, Osaka, 565-0871, Japan
5 shared publicationsShintaro Shichinohe
Department of Molecular Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan
5 shared publications
Latest Publications
- Open Access
- 5 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
A divergent betacoronavirus with a functional furin cleavage site in South American bats
Bats are natural reservoirs for a wide range of RNA viruses. Members of the genus Betacoronavirus, including Severe Acute Respiratory Syndrome virus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome virus (MERS-CoV), have attracted particular attention due to their recent zoonotic emergence. However, much of the known diversity of betacoronaviruses is based on data from Asia, Africa, and Europe, with limited genomic information available from the Americas. Herein, we report the complete genome of a betacoronavirus identified from a Pteronotus parnellii bat sampled in Brazil. Phylogenetic analysis reveals that this virus is sufficiently distinct from the five recognized Betacoronavirus subgenera to represent a new subgenus. Of note, the spike protein of this bat coronavirus possesses a functional furin cleavage site at the S1/S2 junction with a distinct amino acid sequence motif (RDAR) that differs from that found in SARS-CoV-2 (RRAR) by only one amino acid. Comparative structural analysis identifies other betacoronaviruses in bats with furin cleavage sites at the S1/S2 junction, suggesting that this region is a structurally permissive “hotspot” for cleavage site incorporation. Our study provides a broader understanding of the phylogenetic and functional diversity of bat coronaviruses, offering evolutionary context for features that may be relevant to zoonotic potential.
- 5 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessA divergent betacoronavirus with a functional furin cleavage site in South American bats
Bats are natural reservoirs for a wide range of RNA viruses. Members of the genus Betacoronavirus, including Severe Acute Respiratory Syndrome virus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome virus (MERS-CoV), have attracted particular attention due to their recent zoonotic emergence. However, much of the known diversity of betacoronaviruses is based on data from Asia, Africa, and Europe, with limited genomic information available from the Americas. Herein, we report the complete genome of a betacoronavirus identified from a Pteronotus parnellii bat sampled in Brazil. Phylogenetic analysis reveals that this virus is sufficiently distinct from the five recognized Betacoronavirus subgenera to represent a new subgenus. Of note, the spike protein of this bat coronavirus possesses a functional furin cleavage site at the S1/S2 junction with a distinct amino acid sequence motif (RDAR) that differs from that found in SARS-CoV-2 (RRAR) by only one amino acid. Comparative structural analysis identifies other betacoronaviruses in bats with furin cleavage sites at the S1/S2 junction, suggesting that this region is a structurally permissive “hotspot” for cleavage site incorporation. Our study provides a broader understanding of the phylogenetic and functional diversity of bat coronaviruses, offering evolutionary context for features that may be relevant to zoonotic potential.
- Open Access
- 22 January 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100746
Oral SARS-CoV-2 inoculation leads to distinct viral distribution compared to nasal inoculation in a Syrian hamster model
- 22 January 2026
- Published by Elsevier in Journal of Oral Biosciences
- Vol. 68 (1) , 100746
Open AccessOral SARS-CoV-2 inoculation leads to distinct viral distribution compared to nasal inoculation in a Syrian hamster model
- Open Access
- 6 January 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (1) , e0109725
Characterization of H5N1 high pathogenicity avian influenza virus belonging to clade 2.3.4.4b isolated from Ezo red fox in Japan in a mouse model
H5N1 high pathogenicity avian influenza virus (HPAIV) has spread in wild birds and poultry worldwide. H5N1 HPAIV belonging to the currently predominant clade 2.3.4.4b has infected not only birds but also mammals (wild and domestic animals), with several human infections also being reported, raising concerns for public health. In 2022, a clade 2.3.4.4b H5N1 HPAIV strain, A/Ezo red fox/Hokkaido/1/2022 (H5N1; Fox/Hok/1/22), was isolated from an Ezo red fox ( Vulpes vulpes schrencki ) in Hokkaido, Japan; this was the first reported case of clade 2.3.4.4b H5N1 HPAIV isolation from a mammalian species in Japan. Several amino acid substitutions in the PB2 protein play an important role in the adaptation of avian influenza viruses to mammals, but Fox/Hok/1/22 PB2 does not have any of these well-known mammalian-adapting PB2 substitutions. Here, we investigated the biological properties of Fox/Hok/1/22 in a mouse model and found that this virus was highly virulent in mice and replicated well in multiple organs, including the lungs and brain. We then examined whether viruses isolated from these organs acquired known mammalian-adapting PB2 amino acid substitutions, such as PB2 E627K. Deep sequencing analysis of viral RNA from mouse brain and lungs revealed that virus with PB2-627E was predominant in three of four mice, whereas the PB2-627K substitution was predominant in one mouse. These results indicate that Fox/Hok/1/22 is highly virulent in mice despite lacking known PB2 substitutions involved in mammalian adaptation. IMPORTANCE: The H5N1 avian influenza virus has caused severe disease in birds worldwide and is now spreading to mammals, including humans. In 2022, this virus was detected for the first time in an Ezo red fox in Japan. To understand its potential impact on mammals, we studied this virus in mice and found that it caused severe illness, spreading to multiple organs, including the lungs and brain. Surprisingly, despite lacking genetic mutations typically associated with mammalian adaptation, the virus was highly virulent in mice. This finding suggests that the H5N1 virus may pose a greater threat to mammals, including humans, than previously thought. Given their continued spread among wild and domestic animals, our findings underscore the urgent need to monitor how recent H5N1 viruses behave in mammals.
- 6 January 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (1) , e0109725
Open AccessCharacterization of H5N1 high pathogenicity avian influenza virus belonging to clade 2.3.4.4b isolated from Ezo red fox in Japan in a mouse model
H5N1 high pathogenicity avian influenza virus (HPAIV) has spread in wild birds and poultry worldwide. H5N1 HPAIV belonging to the currently predominant clade 2.3.4.4b has infected not only birds but also mammals (wild and domestic animals), with several human infections also being reported, raising concerns for public health. In 2022, a clade 2.3.4.4b H5N1 HPAIV strain, A/Ezo red fox/Hokkaido/1/2022 (H5N1; Fox/Hok/1/22), was isolated from an Ezo red fox ( Vulpes vulpes schrencki ) in Hokkaido, Japan; this was the first reported case of clade 2.3.4.4b H5N1 HPAIV isolation from a mammalian species in Japan. Several amino acid substitutions in the PB2 protein play an important role in the adaptation of avian influenza viruses to mammals, but Fox/Hok/1/22 PB2 does not have any of these well-known mammalian-adapting PB2 substitutions. Here, we investigated the biological properties of Fox/Hok/1/22 in a mouse model and found that this virus was highly virulent in mice and replicated well in multiple organs, including the lungs and brain. We then examined whether viruses isolated from these organs acquired known mammalian-adapting PB2 amino acid substitutions, such as PB2 E627K. Deep sequencing analysis of viral RNA from mouse brain and lungs revealed that virus with PB2-627E was predominant in three of four mice, whereas the PB2-627K substitution was predominant in one mouse. These results indicate that Fox/Hok/1/22 is highly virulent in mice despite lacking known PB2 substitutions involved in mammalian adaptation. IMPORTANCE: The H5N1 avian influenza virus has caused severe disease in birds worldwide and is now spreading to mammals, including humans. In 2022, this virus was detected for the first time in an Ezo red fox in Japan. To understand its potential impact on mammals, we studied this virus in mice and found that it caused severe illness, spreading to multiple organs, including the lungs and brain. Surprisingly, despite lacking genetic mutations typically associated with mammalian adaptation, the virus was highly virulent in mice. This finding suggests that the H5N1 virus may pose a greater threat to mammals, including humans, than previously thought. Given their continued spread among wild and domestic animals, our findings underscore the urgent need to monitor how recent H5N1 viruses behave in mammals.
- Open Access
- 1 December 2025
- Published by Wiley in Microbiology and Immunology
- Vol. 70 (2) , 68-79
Hydroxypropyl Cellulose Enhances Immune Responses to the Current Seasonal Influenza Vaccine in Mice
Influenza A and B viruses cause annual epidemics and continue to pose global public health concerns. The most effective approach to preventing or mitigating the severity of influenza is vaccination. Inactivated split influenza HA vaccines are commonly used worldwide due to their strong safety profile and broad range of target groups; however, their efficacy is suboptimal, especially in the elderly. Adjuvants are used to enhance the effectiveness of some influenza vaccines, but few adjuvants have been approved for human vaccines. Previously, we identified hydroxypropyl cellulose as a promising adjuvant for the split influenza HA vaccine for the 2015–2016 and 2016–2017 influenza seasons. Here, we evaluated whether hydroxypropyl cellulose could enhance the efficacy of the quadrivalent split HA vaccine for the 2023–2024 influenza season, which contains the HA proteins of A/Victoria/4897/2022 (H1N1)pdm09 and three other strains. Using a mouse model, we performed immunogenicity studies and assessed protective efficacy against challenges with homologous and heterologous H1N1pdm09 virus strains. We found that hydroxypropyl cellulose in combination with the HA vaccine generated higher virus‐specific IgG antibody titers compared to the vaccine alone. The adjuvanted vaccine provided complete protection against homologous challenge and enhanced viral clearance from respiratory organs. Notably, the adjuvanted vaccine demonstrated cross‐protective efficacy against heterologous H1N1pdm09 virus challenge, improving survival rates compared to vaccine alone. Our results demonstrate that hydroxypropyl cellulose has potential as an adjuvant for current seasonal influenza vaccines.
- 1 December 2025
- Published by Wiley in Microbiology and Immunology
- Vol. 70 (2) , 68-79
Open AccessHydroxypropyl Cellulose Enhances Immune Responses to the Current Seasonal Influenza Vaccine in Mice
Influenza A and B viruses cause annual epidemics and continue to pose global public health concerns. The most effective approach to preventing or mitigating the severity of influenza is vaccination. Inactivated split influenza HA vaccines are commonly used worldwide due to their strong safety profile and broad range of target groups; however, their efficacy is suboptimal, especially in the elderly. Adjuvants are used to enhance the effectiveness of some influenza vaccines, but few adjuvants have been approved for human vaccines. Previously, we identified hydroxypropyl cellulose as a promising adjuvant for the split influenza HA vaccine for the 2015–2016 and 2016–2017 influenza seasons. Here, we evaluated whether hydroxypropyl cellulose could enhance the efficacy of the quadrivalent split HA vaccine for the 2023–2024 influenza season, which contains the HA proteins of A/Victoria/4897/2022 (H1N1)pdm09 and three other strains. Using a mouse model, we performed immunogenicity studies and assessed protective efficacy against challenges with homologous and heterologous H1N1pdm09 virus strains. We found that hydroxypropyl cellulose in combination with the HA vaccine generated higher virus‐specific IgG antibody titers compared to the vaccine alone. The adjuvanted vaccine provided complete protection against homologous challenge and enhanced viral clearance from respiratory organs. Notably, the adjuvanted vaccine demonstrated cross‐protective efficacy against heterologous H1N1pdm09 virus challenge, improving survival rates compared to vaccine alone. Our results demonstrate that hydroxypropyl cellulose has potential as an adjuvant for current seasonal influenza vaccines.
- Open Access
A cattle-derived human H5N1 isolate suppresses innate immunity despite efficient replication in human respiratory organoids
Summary: The H5N1 high pathogenicity avian influenza virus (HPAIV) of clade 2.3.4.4b, which spreads globally via wild birds, has become a major public health concern because it can infect a variety of mammals, including humans. In 2024, infection of dairy cattle with H5N1 HPAIV clade 2.3.4.4b was confirmed in the United States, and subsequent human cases were reported. Although these viruses are highly pathogenic in animal models, human infections have generally been mild, revealing a striking discrepancy. Here, we characterized the cattle-derived human H5N1 isolate A/Texas/37/2024 (TX37-H5N1) using three-dimensional human respiratory organoids derived from induced pluripotent stem (iPS) cells. Despite efficient replication, TX37-H5N1 induced minimal interferon and inflammatory cytokine responses. Bulk and single-cell RNA sequencing revealed reduced STAT1-mediated transcriptional activity in TX37-H5N1-infected organoids compared to the historic H5N1 human isolate A/Vietnam/1203/2004. These findings suggest that TX37-H5N1 fails to trigger the strong innate responses, including robust cytokine production, that are typically associated with severe H5N1 disease and are thought to contribute to cytokine storm-medicated pathogenesis. This attenuated response may help explain the discrepancy between the high pathogenicity of TX37-H5N1 in animal models and its mild clinical presentation in humans. While zoonotic influenza risk is often assessed using cell lines or animal models, our study highlights the value of using human respiratory organoids to evaluate human-specific virus-host interactions. This platform provides a complementary tool for assessing the risk of emerging avian influenza viruses. Highlights: Human respiratory organoids were used to model zoonotic B3.13 H5N1 infections. A cattle-derived human isolate, TX37-H5N1, replicated more efficiently than historical VN1203-H5N1. TX37-H5N1 suppressed STAT–IRF-mediated innate immune responses. TX37-H5N1 was sensitive to baloxavir and oseltamivir but less sensitive to favipiravir. Human respiratory organoids offer a complementary platform for zoonotic influenza risk assessment. In brief: Our study used human iPSC-derived respiratory organoids to investigate the mild clinical presentation of zoonotic B3.13 H5N1 viruses. We found that TX37-H5N1 replicates efficiently but suppresses innate immune responses, providing mechanistic insight into species-specific pathogenesis and highlighting the utility of human organoids for zoonotic risk assessment.
Open AccessA cattle-derived human H5N1 isolate suppresses innate immunity despite efficient replication in human respiratory organoids
Summary: The H5N1 high pathogenicity avian influenza virus (HPAIV) of clade 2.3.4.4b, which spreads globally via wild birds, has become a major public health concern because it can infect a variety of mammals, including humans. In 2024, infection of dairy cattle with H5N1 HPAIV clade 2.3.4.4b was confirmed in the United States, and subsequent human cases were reported. Although these viruses are highly pathogenic in animal models, human infections have generally been mild, revealing a striking discrepancy. Here, we characterized the cattle-derived human H5N1 isolate A/Texas/37/2024 (TX37-H5N1) using three-dimensional human respiratory organoids derived from induced pluripotent stem (iPS) cells. Despite efficient replication, TX37-H5N1 induced minimal interferon and inflammatory cytokine responses. Bulk and single-cell RNA sequencing revealed reduced STAT1-mediated transcriptional activity in TX37-H5N1-infected organoids compared to the historic H5N1 human isolate A/Vietnam/1203/2004. These findings suggest that TX37-H5N1 fails to trigger the strong innate responses, including robust cytokine production, that are typically associated with severe H5N1 disease and are thought to contribute to cytokine storm-medicated pathogenesis. This attenuated response may help explain the discrepancy between the high pathogenicity of TX37-H5N1 in animal models and its mild clinical presentation in humans. While zoonotic influenza risk is often assessed using cell lines or animal models, our study highlights the value of using human respiratory organoids to evaluate human-specific virus-host interactions. This platform provides a complementary tool for assessing the risk of emerging avian influenza viruses. Highlights: Human respiratory organoids were used to model zoonotic B3.13 H5N1 infections. A cattle-derived human isolate, TX37-H5N1, replicated more efficiently than historical VN1203-H5N1. TX37-H5N1 suppressed STAT–IRF-mediated innate immune responses. TX37-H5N1 was sensitive to baloxavir and oseltamivir but less sensitive to favipiravir. Human respiratory organoids offer a complementary platform for zoonotic influenza risk assessment. In brief: Our study used human iPSC-derived respiratory organoids to investigate the mild clinical presentation of zoonotic B3.13 H5N1 viruses. We found that TX37-H5N1 replicates efficiently but suppresses innate immune responses, providing mechanistic insight into species-specific pathogenesis and highlighting the utility of human organoids for zoonotic risk assessment.
- Open Access
- 22 May 2025
- Published by Springer Nature in npj Viruses
- Vol. 3 (1) , 42
Characterization of A(H1N1)pdm09 influenza viruses isolated between 2016 and 2019
The A(H1N1)pdm09 virus, which caused the 2009 influenza pandemic, has continued to circulate in humans for over a decade. Understanding its biological properties is crucial for effective surveillance, prevention, and control. Here, we characterized recently circulating A(H1N1)pdm09 viruses, focusing on strains isolated between 2016 and 2019. HA gene-based phylogenetic tree analysis revealed that post-pandemic A(H1N1)pdm09 virus strains circulating between 2016 and 2019 form two clusters: subclade 6B.1 and subclade 6B.1 A.5a. Growth kinetics of nine selected representative strains from these clusters showed that subclade 6B.1 viruses replicated well in human lung cells, whereas some subclade 6B.1 A.5a viruses replicated poorly. In vivo, all viruses from both subclades caused significantly less weight loss in infected mice compared to the prototypic pandemic strain A/California/04/2009 (Cal04/2009). Additionally, virus titers in the lungs of mice infected with most viruses from subclade 6B.1 or 6B.1 A.5a were significantly lower than those in mice infected with Cal04/2009. Furthermore, evolutionary analysis suggested multiple transitions to a less pathogenic phenotype, indicating an evolutionary trend towards attenuation. These results demonstrate that A(H1N1)pdm09 viruses isolated between 2016 and 2019 are attenuated in mice, although the mutations responsible for this attenuation require further investigation. Our findings emphasize the need for continued monitoring of A(H1N1)pdm09 viruses to understand their evolutionary dynamics and potential impact on public health.
- 22 May 2025
- Published by Springer Nature in npj Viruses
- Vol. 3 (1) , 42
Open AccessCharacterization of A(H1N1)pdm09 influenza viruses isolated between 2016 and 2019
The A(H1N1)pdm09 virus, which caused the 2009 influenza pandemic, has continued to circulate in humans for over a decade. Understanding its biological properties is crucial for effective surveillance, prevention, and control. Here, we characterized recently circulating A(H1N1)pdm09 viruses, focusing on strains isolated between 2016 and 2019. HA gene-based phylogenetic tree analysis revealed that post-pandemic A(H1N1)pdm09 virus strains circulating between 2016 and 2019 form two clusters: subclade 6B.1 and subclade 6B.1 A.5a. Growth kinetics of nine selected representative strains from these clusters showed that subclade 6B.1 viruses replicated well in human lung cells, whereas some subclade 6B.1 A.5a viruses replicated poorly. In vivo, all viruses from both subclades caused significantly less weight loss in infected mice compared to the prototypic pandemic strain A/California/04/2009 (Cal04/2009). Additionally, virus titers in the lungs of mice infected with most viruses from subclade 6B.1 or 6B.1 A.5a were significantly lower than those in mice infected with Cal04/2009. Furthermore, evolutionary analysis suggested multiple transitions to a less pathogenic phenotype, indicating an evolutionary trend towards attenuation. These results demonstrate that A(H1N1)pdm09 viruses isolated between 2016 and 2019 are attenuated in mice, although the mutations responsible for this attenuation require further investigation. Our findings emphasize the need for continued monitoring of A(H1N1)pdm09 viruses to understand their evolutionary dynamics and potential impact on public health.
- Open Access
- 16 December 2024
- Published by Springer Nature in npj Viruses
- Vol. 2 (1) , 1-7
Influenza B viruses are more susceptible to high temperatures than influenza A viruses
Seasonal influenza is caused by two subtypes of influenza A virus (A/H1N1 and A/H3N2) and two lineages of influenza B viruses (B/Victoria-lineage and B/Yamagata-lineage). Seasonal influenza viruses replicate efficiently in the human upper respiratory tract, where the temperature is 33 °C. In this study, we investigated the susceptibility of seasonal influenza A and B viruses to different temperatures. We examined the differences in viral replication efficiency inside cultured cells and in infectious titre outside cultured cells at different temperatures (i.e., 33 °C, 37 °C, and 39 °C). We found that there were differences in temperature sensitivity between influenza A and B viruses, with influenza B viruses being more temperature sensitive. In addition, we found that cells cultured at 39 °C and infected with influenza B virus showed decreased expression of HA protein with receptor-binding activity on the cell surface. Our findings contribute to our understanding of the properties of seasonal influenza viruses.
- 16 December 2024
- Published by Springer Nature in npj Viruses
- Vol. 2 (1) , 1-7
Open AccessInfluenza B viruses are more susceptible to high temperatures than influenza A viruses
Seasonal influenza is caused by two subtypes of influenza A virus (A/H1N1 and A/H3N2) and two lineages of influenza B viruses (B/Victoria-lineage and B/Yamagata-lineage). Seasonal influenza viruses replicate efficiently in the human upper respiratory tract, where the temperature is 33 °C. In this study, we investigated the susceptibility of seasonal influenza A and B viruses to different temperatures. We examined the differences in viral replication efficiency inside cultured cells and in infectious titre outside cultured cells at different temperatures (i.e., 33 °C, 37 °C, and 39 °C). We found that there were differences in temperature sensitivity between influenza A and B viruses, with influenza B viruses being more temperature sensitive. In addition, we found that cells cultured at 39 °C and infected with influenza B virus showed decreased expression of HA protein with receptor-binding activity on the cell surface. Our findings contribute to our understanding of the properties of seasonal influenza viruses.